Status: current, Defined. Date: 30-Apr 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3083461000168119 | Humira (adalimumab 20 mg / 0.2 mL) injection, 0.2 mL syringe (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3083471000168113 | Humira 20 mg/0.2 mL injection, 0.2 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Humira (adalimumab 20 mg / 0.2 mL) injection, 0.2 mL syringe (trade product unit of use) | Is a | adalimumab 20 mg/0.2 mL injection, syringe | true | Inferred relationship | Some | ||
| Humira (adalimumab 20 mg / 0.2 mL) injection, 0.2 mL syringe (trade product unit of use) | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Humira (adalimumab 20 mg / 0.2 mL) injection, 0.2 mL syringe (trade product unit of use) | Is a | Humira | true | Inferred relationship | Some | ||
| Humira (adalimumab 20 mg / 0.2 mL) injection, 0.2 mL syringe (trade product unit of use) | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
| Humira (adalimumab 20 mg / 0.2 mL) injection, 0.2 mL syringe (trade product unit of use) | has unit of use | syringe | true | Inferred relationship | Some | 239242501 | |
| Humira (adalimumab 20 mg / 0.2 mL) injection, 0.2 mL syringe (trade product unit of use) | has Australian BoSS | adalimumab | true | Inferred relationship | Some | 239242500 | |
| Humira (adalimumab 20 mg / 0.2 mL) injection, 0.2 mL syringe (trade product unit of use) | has intended active ingredient | adalimumab | true | Inferred relationship | Some | 239242500 | |
| Humira (adalimumab 20 mg / 0.2 mL) injection, 0.2 mL syringe (trade product unit of use) | has manufactured dose form | injection | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Humira (adalimumab 20 mg / 0.2 mL) injection, 2 x 0.2 mL syringes (containered trade product pack) | has TPUU | True | Humira (adalimumab 20 mg / 0.2 mL) injection, 0.2 mL syringe (trade product unit of use) | Inferred relationship | Some | 1 |
| Humira 20 mg/0.2 mL injection, 2 x 0.2 mL syringes | has TPUU | True | Humira (adalimumab 20 mg / 0.2 mL) injection, 0.2 mL syringe (trade product unit of use) | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR